Skip to main content
Green Pharmacy
Natural Products Sourcebook
Main menu
Home
1000 Superplants
Bad News for Big Medicine
Pathfinding Naturalists
Natural Products Store
Slide Viewer
Laboratory Medicine
You are here
Home
User login
Username
*
Password
*
Request new password
New Austedo data at 2022 American Psychiatric Association meeting - The Pharma Letter
Submitted by
Anonymous (not verified)
on Tue, 05/24/2022 - 13:44
New Austedo data at 2022 American Psychiatric Association meeting
The Pharma Letter
Teva Presents New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at 2022 American Psychiatric Association Annual Meeting
Business Wire
Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data on Tardive Dyskinesia Improvement and Stability of Psychiatric Symptoms at American Psychiatric Association Annual Meeting 2022
PR Newswire
Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting
Valdosta Daily Times
View Full Coverage on Google News
Log in
to post comments